2,987
Views
212
CrossRef citations to date
0
Altmetric
Review Article

PP2A as a master regulator of the cell cycle

&
Pages 162-184 | Received 30 Oct 2015, Accepted 04 Jan 2016, Published online: 24 Feb 2016

References

  • Abdelmohsen K, Srikantan S, Yang X, et al. (2009). Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J 28:1271–82.
  • Adams DG, Coffee RL Jr, Zhang H, et al. (2005). Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J Biol Chem 280:42644–54.
  • Adler HT, Nallaseth FS, Walter G, Tkachuk DC. (1997). HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A. J Biol Chem 272:28407–14.
  • Afonso O, Matos I, Pereira AJ, et al. (2014). Feedback control of chromosome separation by a midzone Aurora B gradient. Science 345:332–6.
  • Ahn JH, Mcavoy T, Rakhilin SV, et al. (2007a). Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit. Proc Natl Acad Sci USA 104:2979–84.
  • Ahn JH, Sung JY, Mcavoy T, et al. (2007b). The B″/PR72 subunit mediates Ca2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. Proc Natl Acad Sci USA 104:9876–81.
  • Aichem A, Kalveram B, Spinnenhirn V, et al. (2012). The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J Cell Sci 125:4576–85.
  • Alberts AS, Thorburn AM, Shenolikar S, et al. (1993). Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci USA 90:388–92.
  • Alvarado-Kristensson M, Andersson T. (2005). Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem 280:6238–44.
  • Amit S, Hatzubai A, Birman Y, et al. (2002). Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16:1066–76.
  • Ammosova T, Washington K, Debebe Z, et al. (2005). Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Retrovirology 2:47.
  • Arbuckle MI, Komiyama NH, Delaney A, et al. (2010). The SH3 domain of postsynaptic density 95 mediates inflammatory pain through phosphatidylinositol-3-kinase recruitment. EMBO Rep 11:473–8.
  • Arnold HK, Sears RC. (2006). Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 26:2832–44.
  • Arnold HK, Zhang X, Daniel CJ, et al. (2009). The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J 28:500–12.
  • Asencio C, Davidson IF, Santarella-Mellwig R, et al. (2012). Coordination of kinase and phosphatase activities by Lem4 enables nuclear envelope reassembly during mitosis. Cell 150:122–35.
  • Avdi NJ, Malcolm KC, Nick JA, Worthen GS. (2002). A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J Biol Chem 277:40687–96.
  • Baroja ML, Vijayakrishnan L, Bettelli E, et al. (2002). Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J Immunol 168:5070–8.
  • Bauman AL, Apparsundaram S, Ramamoorthy S, et al. (2000). Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571–8.
  • Beaulieu JM, Sotnikova TD, Marion S, et al. (2005). An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261–73.
  • Behrens J, Von Kries JP, Kuhl M, et al. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–42.
  • Bell SP. (2002). The origin recognition complex: from simple origins to complex functions. Genes Dev 16:659–72.
  • Bell SP, Stillman B. (1992). ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature 357:128–34.
  • Belle R, Cormier P, Poulhe R, et al. (1990). Protein phosphorylation during meiotic maturation of Xenopus oocytes: cdc2 protein kinase targets. Int J Dev Biol 34:111–15.
  • Bennett EJ, Rush J, Gygi SP, Harper JW. (2010). Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 143:951–65.
  • Bennin DA, Don AS, Brake T, et al. (2002). Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 277:27449–67.
  • Bishop JD, Nien WL, Dauphinee SM, Too CK. (2006). Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J Endocrinol 190:307–12.
  • Bisson N, James DA, Ivosev G, et al. (2011). Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat Biotechnol 29:653–8.
  • Bobulescu IA, Quinones H, Gisler SM, et al. (2010). Acute regulation of renal Na+/H + exchanger NHE3 by dopamine: role of protein phosphatase 2A. Am J Physiol Renal Physiol 298:F1205–13.
  • Bononi A, Agnoletto C, De Marchi E, et al. (2011). Protein kinases and phosphatases in the control of cell fate. Enzyme Res 2011:329098.
  • Borsotto M, Cavarec L, Bouillot M, et al. (2007). PP2A-Bgamma subunit and KCNQ2 K + channels in bipolar disorder. Pharmacogenomics J 7:123–32.
  • Breitman M, Zilberberg A, Caspi M, Rosin-Arbesfeld R. (2008). The armadillo repeat domain of the APC tumor suppressor protein interacts with Striatin family members. Biochim Biophys Acta 1783:1792–802.
  • Brown EJ, Albers MW, Shin TB, et al. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756–8.
  • Brown VD, Phillips RA, Gallie BL. (1999). Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol 19:3246–56.
  • Burnett PE, Barrow RK, Cohen NA, et al. (1998). RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci USA 95:1432–7.
  • Cafferkey R, Young PR, Mclaughlin MM, et al. (1993). Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol 13:6012–23.
  • Cannavo E, Gerrits B, Marra G, et al. (2007). Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J Biol Chem 282:2976–86.
  • Carlson CJ, White MF, Rondinone CM. (2004). Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem Biophys Res Commun 316:533–9.
  • Carmena M, Wheelock M, Funabiki H, Earnshaw WC. (2012). The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat Rev Mol Cell Biol 13:789–803.
  • Chan SF, Sucher NJ. (2001). An NMDA receptor signaling complex with protein phosphatase 2A. J Neurosci 21:7985–92.
  • Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, et al. (2015). The BioGRID interaction database: 2015 update. Nucleic Acids Res 43:D470–8.
  • Chen GI, Tisayakorn S, Jorgensen C, et al. (2008). PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. J Biol Chem 283:29273–84.
  • Chen HW, Yang CC, Hsieh CL, et al. (2013). A functional genomic approach reveals the transcriptional role of EDD in the expression and function of angiogenesis regulator ACVRL1. Biochim Biophys Acta 1829:1309–19.
  • Chen J, Alberts I, Li X. (2014). Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Int J Dev Neurosci 35:35–41.
  • Cho US, Xu W. (2007). Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445:53–7.
  • Chowdhury D, Keogh MC, Ishii H, et al. (2005). gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 20:801–9.
  • Chuang JY, Wang SA, Yang WB, et al. (2012). Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene 31:4946–59.
  • Cicchillitti L, Fasanaro P, Biglioli P, et al. (2003). Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130. J Biol Chem 278:19509–17.
  • Clevers H, Nusse R. (2012). Wnt/β-catenin signaling and disease. Cell 149:1192–205.
  • Colland F, Jacq X, Trouplin V, et al. (2004). Functional proteomics mapping of a human signaling pathway. Genome Res 14:1324–32.
  • Cox JL, Wilder PJ, Gilmore JM, et al. (2013). The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. PLoS One 8:e62857.
  • Crews CM, Alessandrini A, Erikson RL. (1992). The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 258:478–80.
  • Creyghton MP, Roel G, Eichhorn PJ, et al. (2005). PR72, a novel regulator of Wnt signaling required for Naked cuticle function. Genes Dev 19:376–86.
  • Creyghton MP, Roel G, Eichhorn PJ, et al. (2006). PR130 is a modulator of the Wnt-signaling cascade that counters repression of the antagonist Naked cuticle. Proc Natl Acad Sci USA 103:5397–402.
  • Crossthwaite AJ, Ciruela A, Rayner TF, Cooper DM. (2006). A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A. Mol Pharmacol 69:608–17.
  • Dagda RK, Barwacz CA, Cribbs JT, Strack S. (2005). Unfolding-resistant translocase targeting: a novel mechanism for outer mitochondrial membrane localization exemplified by the Bbeta2 regulatory subunit of protein phosphatase 2A. J Biol Chem 280:27375–82.
  • Dajani R, Fraser E, Roe SM, et al. (2003). Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J 22:494–501.
  • Davis AJ, Yan Z, Martinez B, Mumby MC. (2008). Protein phosphatase 2A is targeted to cell division control protein 6 by a calcium-binding regulatory subunit. J Biol Chem 283:16104–14.
  • Dehde S, Rohaly G, Schub O, et al. (2001). Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol 21:2581–93.
  • Dobierzewska A, Giltiay NV, Sabapathi S, et al. (2011). Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta. J Biol Chem 286:32064–73.
  • Dodge-Kafka KL, Bauman A, Mayer N, et al. (2010). cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3. J Biol Chem 285:11078–86.
  • Dohoney KM, Guillerm C, Whiteford C, et al. (2004). Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene 23:49–57.
  • Dominguez-Brauer C, Brauer PM, Chen YJ, et al. (2010). Tumor suppression by ARF: gatekeeper and caretaker. Cell Cycle 9:86–9.
  • Dovega R, Tsutakawa S, Quistgaard EM, et al. (2014). Structural and biochemical characterization of human PR70 in isolation and in complex with the scaffolding subunit of protein phosphatase 2A. PLoS One 9:e101846.
  • Duncker BP, Chesnokov IN, Mcconkey BJ. (2009). The origin recognition complex protein family. Genome Biol 10:214.
  • Egan SE, Giddings BW, Brooks MW, et al. (1993). Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45–51.
  • Eichhorn PJ, Creyghton MP, Bernards R. (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795:1–15.
  • Eichhorn PJ, Creyghton MP, Wilhelmsen K, et al. (2007). A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC. PLoS Genet 3:e218.
  • Ewing RM, Chu P, Elisma F, et al. (2007). Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3:89.
  • Fan GH, Yang W, Sai J, Richmond A. (2001). Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme. J Biol Chem 276:16960–8.
  • Ferrarese A, Marin O, Bustos VH, et al. (2007). Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3. Biochemistry 46:11902–10.
  • Firulli BA, Howard MJ, Mcdaid JR, et al. (2003). PKA, PKC, and the protein phosphatase 2A influence HAND factor function: a mechanism for tissue-specific transcriptional regulation. Mol Cell 12:1225–37.
  • Fisher D, Krasinska L, Coudreuse D, Novak B. (2012). Phosphorylation network dynamics in the control of cell cycle transitions. J Cell Sci 125:4703–11.
  • Foerster S, Kacprowski T, Dhople VM, et al. (2013). Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics. Proteomics 13:3131–44.
  • Foley EA, Maldonado M, Kapoor TM. (2011). Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase. Nat Cell Biol 13:1265–71.
  • Forester CM, Maddox J, Louis JV, et al. (2007). Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proc Natl Acad Sci USA 104:19867–72.
  • Franklin CC, Kraft AS. (1997). Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272:16917–23.
  • Franklin CC, Srikanth S, Kraft AS. (1998). Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci USA 95:3014–19.
  • Freedman TS, Sondermann H, Friedland GD, et al. (2006). A Ras-induced conformational switch in the Ras activator Son of sevenless. Proc Natl Acad Sci USA 103:16692–7.
  • Fritz A, Brayer KJ, Mccormick N, et al. (2006). Phosphorylation of serine 526 is required for MEKK3 activity, and association with 14-3-3 blocks dephosphorylation. J Biol Chem 281:6236–45.
  • Fruman DA, Rommel C. (2014). PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13:140–56.
  • Fu DX, Kuo YL, Liu BY, et al. (2003). Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A. J Biol Chem 278:1487–93.
  • Fuhrer DK, Yang YC. (1996). Complex formation of JAK2 with PP2A, P13K, and Yes in response to the hematopoietic cytokine interleukin-11. Biochem Biophys Res Commun 224:289–96.
  • Galea MA, Eleftheriou A, Henderson BR. (2001). ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A. J Biol Chem 276:45833–9.
  • Garriga J, Jayaraman AL, Limon A, et al. (2004). A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. Cell Cycle (Georgetown, Tx) 3:1320–30.
  • Gautier J, Solomon MJ, Booher RN, et al. (1991). cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67:197–211.
  • Gil-Bernabe AM, Romero F, Limon-Mortes MC, Tortolero M. (2006). Protein phosphatase 2A stabilizes human securin, whose phosphorylated forms are degraded via the SCF ubiquitin ligase. Mol Cell Biol 26:4017–27.
  • Glatter T, Wepf A, Aebersold R, Gstaiger M. (2009). An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol 5:237.
  • Goodarzi AA, Jonnalagadda JC, Douglas P, et al. (2004). Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J 23:4451–61.
  • Gordon J, Hwang J, Carrier KJ, et al. (2011). Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem 12:54.
  • Gotz J, Probst A, Mistl C, et al. (2000). Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development. Mech Dev 93:83–93.
  • Grant MM. (2010). Identification of SUMOylated proteins in neuroblastoma cells after treatment with hydrogen peroxide or ascorbate. BMB Rep 43:720–5.
  • Greco TM, Yu F, Guise AJ, Cristea IM. (2011). Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Mol Cell Proteomics 10:M110.004317.
  • Griswold-Prenner I, Kamibayashi C, Maruoka EM, et al. (1998). Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 18:6595–604.
  • Guo F, Stanevich V, Wlodarchak N, et al. (2014). Structural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone. Cell Res 24:190–203.
  • Guo Z, Song E, Ma S, et al. (2012). Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. J Proteome Res 11:4847–62.
  • Guttinger S, Laurell E, Kutay U. (2009). Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 10:178–91.
  • Ha NC, Tonozuka T, Stamos JL, et al. (2004). Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15:511–21.
  • Hagstrom KA, Meyer BJ. (2003). Condensin and cohesin: more than chromosome compactor and glue. Nat Rev Genet 4:520–34.
  • Hall DD, Feekes JA, Arachchige Don AS, et al. (2006). Binding of protein phosphatase 2A to the L-type calcium channel Cav1.2 next to Ser1928, its main PKA site, is critical for Ser1928 dephosphorylation. Biochemistry 45:3448–59.
  • Harbour JW, Dean DC. (2000). Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2:E65–7.
  • Hartley D, Cooper GM. (2002). Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. J Cell Biochem 85:304–14.
  • Harvey SL, Enciso G, Dephoure N, et al. (2011). A phosphatase threshold sets the level of Cdk1 activity in early mitosis in budding yeast. Mol Biol Cell 22:3595–608.
  • Hashigasako A, Machide M, Nakamura T, Matsumoto K. (2004). Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 279:26445–52.
  • He TC, Sparks AB, Rago C, et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281:1509–12.
  • Hegarat N, Vesely C, Vinod PK, et al. (2014). PP2A/B55 and Fcp1 Regulate Greatwall and Ensa Dephosphorylation during Mitotic Exit. PLoS Genet 10:e1004004.
  • Heijman J, Dewenter M, El-Armouche A, Dobrev D. (2013). Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. J Mol Cell Cardiol 64:90–8.
  • Heikkinen PT, Nummela M, Leivonen SK, et al. (2010). Hypoxia-activated Smad3-specific dephosphorylation by PP2A. J Biol Chem 285:3740–9.
  • Hirschi A, Cecchini M, Steinhardt RC, et al. (2010). An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol 17:1051–7.
  • Hoffmann C, Gaietta G, Bunemann M, et al. (2005). A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods 2:171–6.
  • Holland AJ, Bottger F, Stemmann O, Taylor SS. (2007). Protein phosphatase 2A and separase form a complex regulated by separase autocleavage. J Biol Chem 282:24623–32.
  • Holt LJ. (2012). Regulatory modules: coupling protein stability to phopshoregulation during cell division. FEBS Lett 586:2773–7.
  • Hommes DW, Peppelenbosch MP, Deventer SJHV. (2003). Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52:144–51
  • Horn V, Thelu J, Garcia A, et al. (2007). Functional interaction of Aurora-A and PP2A during mitosis. Mol Biol Cell 18:1233–41.
  • Hsu PP, Kang SA, Rameseder J, et al. (2011). The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332:1317–22.
  • Huang HK, Forsburg SL, John UP, et al. (2001). Isolation and characterization of the Pin1/Ess1p homologue in Schizosaccharomyces pombe. J Cell Sci 114:3779–88.
  • Hunter T. (1995). Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225–36.
  • Hutchins JR, Dikovskaya D, Clarke PR. (2003). Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II. Mol Biol Cell 14:4003–14.
  • Hyrien O, Rappailles A, Guilbaud G, et al. (2013). From simple bacterial and archaeal replicons to replication N/U-domains. J Mol Biol 425:4673–89.
  • Imajo M, Tsuchiya Y, Nishida E. (2006). Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 58:312–17.
  • Indovina P, Marcelli E, Casini N, et al. (2013). Emerging roles of RB family: new defense mechanisms against tumor progression. J Cell Physiol 228:525–35.
  • Inoki K, Ouyang H, Zhu T, et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955–68.
  • Ishiguro T, Tanaka K, Sakuno T, Watanabe Y. (2010). Shugoshin-PP2A counteracts casein-kinase-1-dependent cleavage of Rec8 by separase. Nat Cell Biol 12:500–6.
  • Ito A, Kataoka TR, Watanabe M, et al. (2000). A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO J 19:562–71.
  • Jackson JB, Pallas DC. (2012). Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner. Neoplasia 14:585–99.
  • Jager S, Cimermancic P, Gulbahce N, et al. (2012). Global landscape of HIV-human protein complexes. Nature 481:365–70.
  • Jallepalli PV, Brown GW, Muzi-Falconi M, et al. (1997). Regulation of the replication initiator protein p65cdc18 by CDK phosphorylation. Genes Dev 11:2767–79.
  • Janssens V, Goris J. (2001). Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417–39.
  • Janssens V, Longin S, Goris J. (2008). PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 33:113–21.
  • Jaumot M, Hancock JF. (2001). Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20:3949–58.
  • Jayadeva G, Kurimchak A, Garriga J, et al. (2010). B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation. J Biol Chem 285:29863–73.
  • Jessberger R. (2002). The many functions of SMC proteins in chromosome dynamics. Nat Rev Mol Cell Biol 3:767–78.
  • Jho E, Lomvardas S, Costantini F. (1999). A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Biochem Biophys Res Commun 266:28–35.
  • Jiang L, Stanevich V, Satyshur KA, et al. (2013). Structural basis of protein phosphatase 2A stable latency. Nat Commun 4:1699.
  • Johnson ES, Kornbluth S. (2012). Phosphatases driving mitosis: pushing the gas and lifting the brakes. Prog Mol Biol Transl Sci 106:327–41.
  • Joshi P, Greco TM, Guise AJ, et al. (2013). The functional interactome landscape of the human histone deacetylase family. Mol Syst Biol 9:672.
  • Julius MA, Schelbert B, Hsu W, et al. (2000). Domains of axin and disheveled required for interaction and function in wnt signaling. Biochem Biophys Res Commun 276:1162–9.
  • Junttila MR, Puustinen P, Niemela M, et al. (2007). CIP2A inhibits PP2A in human malignancies. Cell 130:51–62.
  • Kanemitsu MY, Jiang W, Eckhart W. (1998). Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ 9:13–21.
  • Kawabe T, Muslin AJ, Korsmeyer SJ. (1997). HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. Nature 385:454–8.
  • Keen JC, Zhou Q, Park BH, et al. (2005). Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability. J Biol Chem 280:29519–24.
  • Kiely PA, O'Gorman D, Luong K, et al. (2006). Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration. Mol Cell Biol 26:4041–51.
  • Kim DH, Sarbassov DD, Ali SM, et al. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–75.
  • Kim DH, Sarbassov DD, Ali SM, et al. (2003). GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11:895–904.
  • Kim J, Kundu M, Viollet B, Guan KL. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132–41.
  • Kim ST, Lim DS, Canman CE, Kastan MB. (1999). Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274:37538–43.
  • Kinzler KW, Nilbert MC, Su LK, et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253:661–5.
  • Kitajima TS, Sakuno T, Ishiguro K, et al. (2006). Shugoshin collaborates with protein phosphatase 2A to protect cohesin. Nature 441:46–52.
  • Klippel A, Kavanaugh WM, Pot D, Williams LT. (1997). A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 17:338–44.
  • Kolupaeva V, Daempfling L, Basilico C. (2013). The B55alpha regulatory subunit of protein phosphatase 2A mediates fibroblast growth factor-induced p107 dephosphorylation and growth arrest in chondrocytes. Mol Cell Biol 33:2865–78.
  • Kolupaeva V, Janssens V. (2013). PP1 and PP2A phosphatases–cooperating partners in modulating retinoblastoma protein activation. FEBS J 280:627–43.
  • Kotlo K, Johnson KR, Grillon JM, et al. (2012). Phosphoprotein abundance changes in hypertensive cardiac remodeling. J Proteomics 77:1–13.
  • Krahn MP, Egger-Adam D, Wodarz A. (2009). PP2A antagonizes phosphorylation of Bazooka by PAR-1 to control apical-basal polarity in dividing embryonic neuroblasts. Dev Cell 16:901–8.
  • Kray AE, Carter RS, Pennington KN, et al. (2005). Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A. J Biol Chem 280:35974–82.
  • Kristensen AR, Gsponer J, Foster LJ. (2012). A high-throughput approach for measuring temporal changes in the interactome. Nat Methods 9:907–9.
  • Krueger KM, Daaka Y, Pitcher JA, Lefkowitz RJ. (1997). The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem 272:5–8.
  • Kumar A, Pandurangan AK, Lu F, et al. (2012). Chemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3beta pathway in colon cancer. Carcinogenesis 33:1726–35.
  • Kunz J, Henriquez R, Schneider U, et al. (1993). Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73:585–96.
  • Kuo YC, Huang KY, Yang CH, et al. (2008). Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283:1882–92.
  • Kurimchak A, Grana X. (2012). PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates. Gene 499:1–7.
  • Lammer C, Wagerer S, Saffrich R, et al. (1998). The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111:2445–53.
  • Landsverk HB, Kirkhus M, Bollen M, et al. (2005). PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner. Biochem J 390:709–17.
  • Lao DH, Yusoff P, Chandramouli S, et al. (2007). Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J Biol Chem 282:9117–26.
  • Laplante M, Sabatini DM. (2012). mTOR signaling in growth control and disease. Cell 149:274–93.
  • Latres E, Chiaur DS, Pagano M. (1999). The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18:849–54.
  • Laurell E, Beck K, Krupina K, et al. (2011). Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry. Cell 144:539–50.
  • Lechward K, Zolnierowicz S, Hemmings BA. (1999). Eukaryotic translation termination factor 1 associates with protein phosphatase 2A and targets it to ribosomes. Biochemistry (Mosc) 64:1373–81.
  • Lee JA, Pallas DC. (2007). Leucine carboxyl methyltransferase-1 is necessary for normal progression through mitosis in mammalian cells. J Biol Chem 282:30974–84.
  • Lee WJ, Kim DU, Lee MY, Choi KY. (2007). Identification of proteins interacting with the catalytic subunit of PP2A by proteomics. Proteomics 7:206–14.
  • Lees JA, Buchkovich KJ, Marshak DR, et al. (1991). The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J 10:4279–90.
  • Letourneux C, Rocher G, Porteu F. (2006). B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J 25:727–38.
  • Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan GE. (2001). Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J 20:2160–70.
  • Leung-Pineda V, Ryan CE, Piwnica-Worms H. (2006). Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol Cell Biol 26:7529–38.
  • Li HH, Cai X, Shouse GP, et al. (2007). A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J 26:402–11.
  • Li M, Makkinje A, Damuni Z. (1996). The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 271:11059–62.
  • Li S, Wang L, Berman MA, et al. (2006). RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol Cell 24:497–509.
  • Liang C, Weinreich M, Stillman B. (1995). ORC and Cdc6p interact and determine the frequency of initiation of DNA replication in the genome. Cell 81:667–76.
  • Liedtke CM, Wang X, Smallwood ND. (2005). Role for protein phosphatase 2A in the regulation of Calu-3 epithelial Na+-K+-2Cl-, type 1 co-transport function. J Biol Chem 280:25491–8.
  • Lim J, Hao T, Shaw C, et al. (2006). A protein–protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801–14.
  • Lin SS, Bassik MC, Suh H, et al. (2006). PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum. J Biol Chem 281:23003–12.
  • Liu J, Prickett TD, Elliott E, et al. (2001). Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc Natl Acad Sci USA 98:6650–5.
  • Liu L, Eisenman RN. (2012). Regulation of c-Myc protein abundance by a protein phosphatase 2A-glycogen synthase kinase 3β-negative feedback pathway. Genes Cancer 3:23–36.
  • Longin S, Zwaenepoel K, Louis JV, et al. (2007). Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J Biol Chem 282:26971–80.
  • Louis JV, Martens E, Borghgraef P, et al. (2011). Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc Natl Acad Sci USA 108:6957–62.
  • Low C, Quistgaard EM, Kovermann M, et al. (2014). Structural basis for PTPA interaction with the invariant C-terminal tail of PP2A. Biol Chem 395:881–9.
  • Lowe M, Gonatas NK, Warren G. (2000). The mitotic phosphorylation cycle of the cis-Golgi matrix protein GM130. J Cell Biol 149:341–56.
  • Luo W, Peterson A, Garcia BA, et al. (2007). Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J 26:1511–21.
  • Ma J, Arnold HK, Lilly MB, et al. (2007). Negative regulation of Pim-1 protein kinase levels by the B56beta subunit of PP2A. Oncogene 26:5145–53.
  • Ma OK, Sucher NJ. (2004). Molecular interaction of NMDA receptor subunit NR3A with protein phosphatase 2A. Neuroreport 15:1447–50.
  • Ma XM, Blenis J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307–18.
  • Macdonald BT, Tamai K, He X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9–26.
  • Magenta A, Fasanaro P, Romani S, et al. (2008). Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol Cell Biol 28:873–82.
  • Mailand N, Diffley JF. (2005). CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 122:915–26.
  • Manning G, Whyte DB, Martinez R, et al. (2002). The protein kinase complement of the human genome. Science 298:1912–34.
  • Mao L, Yang L, Arora A, et al. (2005). Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons. J Biol Chem 280:12602–10.
  • Margolis SS, Perry JA, Forester CM, et al. (2006a). Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127:759–73.
  • Margolis SS, Perry JA, Weitzel DH, et al. (2006b). A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25. Mol Biol Cell 17:1779–89.
  • Margolis SS, Walsh S, Weiser DC, et al. (2003). PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J 22:5734–45.
  • Marmorstein LY, Mclaughlin PJ, Stanton JB, et al. (2002). Bestrophin interacts physically and functionally with protein phosphatase 2A. J Biol Chem 277:30591–7.
  • Martin L, Latypova X, Wilson CM, et al. (2013). Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A. Ageing Res Rev 12:39–49.
  • Mathiasen DP, Egebjerg C, Andersen SH, et al. (2012). Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation. Oncogene 31:390–401.
  • Mayer C, Zhao J, Yuan X, Grummt I. (2004). mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev 18:423–34.
  • Mcconnell JL, Gomez RJ, Mccorvey LR, et al. (2007). Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway. Oncogene 26:6021–30.
  • Mccubrey JA, Steelman LS, Chappell WH, et al. (2007). Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773:1263–84.
  • Meilleur MA, Akpovi CD, Pelletier RM, Vitale ML. (2007). Tumor necrosis factor-alpha-induced anterior pituitary folliculostellate TtT/GF cell uncoupling is mediated by connexin 43 dephosphorylation. Endocrinology 148:5913–24.
  • Meloche S, Pouyssegur J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26:3227–39.
  • Merrill RA, Slupe AM, Strack S. (2013). N-terminal phosphorylation of protein phosphatase 2A/Bbeta2 regulates translocation to mitochondria, dynamin-related protein 1 dephosphorylation, and neuronal survival. FEBS J 280:662–73.
  • Michniewicz M, Zago MK, Abas L, et al. (2007). Antagonistic regulation of PIN phosphorylation by PP2A and PINOID directs auxin flux. Cell 130:1044–56.
  • Milburn MV, Tong L, Devos AM, et al. (1990). Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science 247:939–45.
  • Mitra A, Menezes ME, Pannell LK, et al. (2012). DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3beta to downregulate beta-catenin transcription target, osteopontin. Oncogene 31:4472–83.
  • Mitsuhashi S, Shima H, Tanuma N, et al. (2005). Protein phosphatase type 2A, PP2A, is involved in degradation of gp130. Mol Cell Biochem 269:183–7.
  • Mochida S, Hunt T. (2012). Protein phosphatases and their regulation in the control of mitosis. EMBO Rep 13:197–203.
  • Mochida S, Ikeo S, Gannon J, Hunt T. (2009). Regulated activity of PP2A-B55 delta is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. EMBO J 28:2777–85.
  • Mochida S, Maslen SL, Skehel M, Hunt T. (2010). Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 330:1670–3.
  • Monje P, Hernandez-Losa J, Lyons RJ, et al. (2005). Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem 280:35081–4.
  • Moreno CS, Park S, Nelson K, et al. (2000). WD40 repeat proteins striatin and S/G2 nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. J Biol Chem 275:5257–63.
  • Mueller PR, Coleman TR, Kumagai A, Dunphy WG. (1995). Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270:86–90.
  • Mumby M. (2001). A new role for protein methylation: switching partners at the phosphatase ball. Sci STKE 2001:pe1
  • Mumby M. (2009). Lab Webpage [Online]. Dallas (TX): UT Southwestern
  • Musacchio A, Salmon ED. (2007). The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8:379–93.
  • Naji S, Ambrus G, Cimermancic P, et al. (2012). Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol Cell Proteomics 11:M111.015313.
  • Nakashima A, Tanimura-Ito K, Oshiro N, et al. (2013). A positive role of mammalian Tip41-like protein, TIPRL, in the amino-acid dependent mTORC1-signaling pathway through interaction with PP2A. FEBS Lett 587:2924–9.
  • Narayanan U, Nalavadi V, Nakamoto M, et al. (2007). FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 27:14349–57.
  • Nevins JR. (2001). The Rb/E2F pathway and cancer. Hum Mol Genet 10:699–703.
  • Nimmo ER, Stevens C, Phillips AM, et al. (2011). TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease. Gastroenterology 141:972–81.e1–2.
  • Nishisho I, Nakamura Y, Miyoshi Y, et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–9.
  • Nishitani H, Lygerou Z, Nishimoto T, Nurse P. (2000). The Cdt1 protein is required to license DNA for replication in fission yeast. Nature 404:625–8.
  • Nojima H, Tokunaga C, Eguchi S, et al. (2003). The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 278:15461–4.
  • Nozawa RS, Nagao K, Masuda HT, et al. (2010). Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nat Cell Biol 12:719–27.
  • Oberg EA, Nifoussi SK, Gingras AC, Strack S. (2012). Selective proteasomal degradation of the B'β subunit of protein phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15. J Biol Chem 287:43378–89.
  • Oellerich T, Bremes V, Neumann K, et al. (2011). The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. EMBO J 30:3620–34.
  • Ohnishi T, Yamashita A, Kashima I, et al. (2003). Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol Cell 12:1187–200.
  • Okamoto K, Kamibayashi C, Serrano M, et al. (1996). p53-dependent association between cyclin G and the B′ subunit of protein phosphatase 2A. Mol Cell Biol 16:6593–602.
  • Okamoto K, Li H, Jensen MR, et al. (2002). Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell 9:761–71.
  • Olah J, Vincze O, Virok D, et al. (2011). Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J Biol Chem 286:34088–100.
  • Ory S, Zhou M, Conrads TP, et al. (2003). Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol 13:1356–64.
  • Palkowitsch L, Leidner J, Ghosh S, Marienfeld RB. (2008). Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity. J Biol Chem 283:76–86.
  • Paolinelli R, Mendoza-Maldonado R, Cereseto A, Giacca M. (2009). Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle. Nat Struct Mol Biol 16:412–20.
  • Paroni G, Cernotta N, Dello Russo C, et al. (2008). PP2A regulates HDAC4 nuclear import. Mol Biol Cell 19:655–67.
  • Peter M, Nakagawa J, Doree M, et al. (1990). Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 60:791–801.
  • Petersen BO, Lukas J, Sorensen CS, et al. (1999). Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J 18:396–410.
  • Peterson RT, Desai BN, Hardwick JS, Schreiber SL. (1999). Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci USA 96:4438–42.
  • Peterson TR, Laplante M, Thoreen CC, et al. (2009). DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137:873–86.
  • Pitman MR, Barr RK, Gliddon BL, et al. (2011). A critical role for the protein phosphatase 2A B'α regulatory subunit in dephosphorylation of sphingosine kinase 1. Int J Biochem Cell Biol 43:342–7.
  • Plesca D, Crosby ME, Gupta D, Almasan A. (2007). E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA. Cell Cycle 6:1147–52.
  • Prickett TD, Brautigan DL. (2007). Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3. Mol Cell Biol 27:4217–27.
  • Purev E, Soprano DR, Soprano KJ. (2011). PP2A interaction with Rb2/p130 mediates translocation of Rb2/p130 into the nucleus in all-trans retinoic acid-treated ovarian carcinoma cells. J Cell Physiol 226:1027–34.
  • Qian J, Beullens M, Lesage B, Bollen M. (2013). Aurora B defines its own chromosomal targeting by opposing the recruitment of the phosphatase scaffold Repo-Man. Curr Biol 23:1136–43.
  • Rajakulendran T, Sahmi M, Lefrancois M, et al. (2009). A dimerization-dependent mechanism drives RAF catalytic activation. Nature 461:542–5.
  • Rajgopal A, Young DW, Mujeeb KA, et al. (2007). Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells. J Cell Biochem 100:1509–17.
  • Ricotta D, Hansen J, Preiss C, et al. (2008). Characterization of a protein phosphatase 2A holoenzyme that dephosphorylates the clathrin adaptors AP-1 and AP-2. J Biol Chem 283:5510–17.
  • Rimerman RA, Gellert-Randleman A, Diehl JA. (2000). Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation. J Biol Chem 275:14736–42.
  • Rual JF, Venkatesan K, Hao T, et al., (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437:1173–8.
  • Rubin SM. (2013). Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci 38:12–9.
  • Rubin SM, Gall AL, Zheng N, Pavletich NP. (2005). Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123:1093–106.
  • Ruvolo VR, Kurinna SM, Karanjeet KB, et al. (2008). PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells. J Biol Chem 283:35474–85.
  • Sablina AA, Chen W, Arroyo JD, et al. (2007). The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 129:969–82.
  • Samstag Y, Nebl G. (2003). Interaction of cofilin with the serine phosphatases PP1 and PP2A in normal and neoplastic human T lymphocytes. Adv Enzyme Regul 43:197–211.
  • Sancak Y, Peterson TR, Shaul YD, et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496–501.
  • Sangodkar J, Farrington C, Mcclinch K, et al. (2015). All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS J. [Epub ahead of print]. doi:10.1111/febs.13573.
  • Saraf A, Oberg EA, Strack S. (2010). Molecular determinants for PP2A substrate specificity: charged residues mediate dephosphorylation of tyrosine hydroxylase by the PP2A/B' regulatory subunit. Biochemistry 49:986–95.
  • Sathyanarayanan S, Zheng X, Xiao R, Sehgal A. (2004). Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2A. Cell 116:603–15.
  • Satoh J, Kawana N, Yamamoto Y. (2013). Pathway analysis of ChIP-Seq-based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogenesis of neurodegenerative diseases. Gene Regul Syst Bio 7:139–52.
  • Schlaitz AL, Srayko M, Dammermann A, et al. (2007). The C. elegans RSA complex localizes protein phosphatase 2A to centrosomes and regulates mitotic spindle assembly. Cell 128:115–27.
  • Schmitz MH, Held M, Janssens V, et al. (2010). Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 12:886–93.
  • Sciarretta S, Volpe M, Sadoshima J. (2014). Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res 114:549–64.
  • Scott GK, Gu F, Crump CM, et al. (2003). The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. EMBO J 22:6234–44.
  • Seeling JM, Miller JR, Gil R, et al. (1999). Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283:2089–91.
  • Seth A, Sheth P, Elias BC, Rao R. (2007). Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J Biol Chem 282:11487–98.
  • Shanley TP, Vasi N, Denenberg A, Wong HR. (2001). The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling. J Immunol 166:966–72.
  • Shern JF, Sharer JD, Pallas DC, et al. (2003). Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. J Biol Chem 278:40829–36.
  • Sheu YJ, Stillman B. (2006). Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. Mol Cell 24:101–13.
  • Shi Y. (2009). Serine/threonine phosphatases: mechanism through structure. Cell 139:468–84.
  • Shimobayashi M, Hall MN. (2014). Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15:155–62.
  • Shin JH, Grabowski B, Kasiviswanathan R, et al. (2003). Regulation of minichromosome maintenance helicase activity by Cdc6. J Biol Chem 278:38059–67.
  • Short KM, Hopwood B, Yi Z, Cox TC. (2002). MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol 3:1.
  • Shtrichman R, Sharf R, Barr H, et al. (1999). Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc Natl Acad Sci USA 96:10080–5.
  • Soprano KJ, Purev E, Vuocolo S, Soprano DR. (2006). Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid. Oncogene 25:5315–25.
  • Sowa ME, Bennett EJ, Gygi SP, Harper JW. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138:389–403.
  • Stanevich V. (2013). Protein phosphatase 2A methylation and stable latency. PhD Thesis, University of Wisconsin-Madison, Madison, WI
  • Stanevich V, Jiang L, Satyshur KA, et al. (2011). The structural basis for tight control of PP2A methylation and function by LCMT-1. Mol Cell 41:331–42.
  • Suijkerbuijk SJ, Vleugel M, Teixeira A, Kops GJ. (2012). Integration of kinase and phosphatase activities by BUBR1 ensures formation of stable kinetochore-microtubule attachments. Dev Cell 23:745–55.
  • Sullivan M, Morgan DO. (2007). Finishing mitosis, one step at a time. Nat Rev Mol Cell Biol 8:894–903.
  • Sumara I, Vorlaufer E, Stukenberg PT, et al. (2002). The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol Cell 9:515–25.
  • Sun L, Stoecklin G, Van Way S, et al. (2007). Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 282:3766–77.
  • Sung U, Jennings JL, Link AJ, Blakely RD. (2005). Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. Biochem Biophys Res Commun 333:671–8.
  • Surpili MJ, Delben TM, Kobarg J. (2003). Identification of proteins that interact with the central coiled-coil region of the human protein kinase NEK1. Biochemistry 42:15369–76.
  • Takahashi K, Suzuki K. (2006). Regulation of protein phosphatase 2A-mediated recruitment of IQGAP1 to beta1 integrin by EGF through activation of Ca2+/calmodulin-dependent protein kinase II. J Cell Physiol 208:213–19.
  • Takahashi M, Shibata H, Shimakawa M, et al. (1999). Characterization of a novel giant scaffolding protein, CG-NAP, that anchors multiple signaling enzymes to centrosome and the golgi apparatus. J Biol Chem 274:17267–74.
  • Takemoto A, Maeshima K, Ikehara T, et al. (2009). The chromosomal association of condensin II is regulated by a noncatalytic function of PP2A. Nat Struct Mol Biol 16:1302–8.
  • Tanaka T, Nasmyth K. (1998). Association of RPA with chromosomal replication origins requires an Mcm protein, and is regulated by Rad53, and cyclin- and Dbf4-dependent kinases. EMBO J 17:5182–91.
  • Tang Z, Shu H, Qi W, et al. (2006). PP2A is required for centromeric localization of Sgo1 and proper chromosome segregation. Dev Cell 10:575–85.
  • Tanno Y, Kitajima TS, Honda T, et al. (2010). Phosphorylation of mammalian Sgo2 by Aurora B recruits PP2A and MCAK to centromeres. Genes Dev 24:2169–79.
  • Tao GZ, Toivola DM, Zhou Q, et al. (2006). Protein phosphatase-2A associates with and dephosphorylates keratin 8 after hyposmotic stress in a site- and cell-specific manner. J Cell Sci 119:1425–32.
  • Thompson LJ, Bollen M, Fields AP. (1997). Identification of protein phosphatase 1 as a mitotic lamin phosphatase. J Biol Chem 272:29693–7.
  • Tischer T, Hormanseder E, Mayer TU. (2012). The APC/C inhibitor XErp1/Emi2 is essential for Xenopus early embryonic divisions. Science 338:520–4.
  • Tran H, Bustos D, Yeh R, et al. (2013). HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction. J Biol Chem 288:3753–67.
  • Trzcinska AM, Girstun A, Piekielko A, et al. (2002). Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display. Mol Biol Rep 29:347–52.
  • Tu LC, Yan X, Hood L, Lin B. (2007). Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics 6:575–88.
  • Turowski P, Myles T, Hemmings BA, et al. (1999). Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell 10:1997–2015.
  • Ugi S, Imamura T, Ricketts W, Olefsky JM. (2002). Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol 22:2375–87.
  • Vagnarelli P, Hudson DF, Ribeiro SA, et al. (2006). Condensin and Repo-Man-PP1 co-operate in the regulation of chromosome architecture during mitosis. Nat Cell Biol 8:1133–42.
  • van Kanegan MJ, Strack S. (2009). The protein phosphatase 2A regulatory subunits B′beta and B'delta mediate sustained TrkA neurotrophin receptor autophosphorylation and neuronal differentiation. Mol Cell Biol 29:662–74.
  • van Noort M, Meeldijk J, van der Zee R, et al. (2002). Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901–5.
  • Varjosalo M, Keskitalo S, van Drogen A, et al. (2013a). The protein interaction landscape of the human CMGC kinase group. Cell Rep 3:1306–20.
  • Varjosalo M, Sacco R, Stukalov A, et al. (2013b). Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods 10:307–14.
  • Varlamov O, Kalinina E, Che FY, Fricker LD. (2001). Protein phosphatase 2A binds to the cytoplasmic tail of carboxypeptidase D and regulates post-trans-Golgi network trafficking. J Cell Sci 114:311–22.
  • Vastiau A, Cao L, Jaspers M, et al. (2005). Interaction of the protein phosphatase 2A with the regulatory domain of the cystic fibrosis transmembrane conductance regulator channel. FEBS Lett 579:3392–6.
  • Virshup DM, Shenolikar S. (2009). From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 33:537–45.
  • Voorhoeve PM, Hijmans EM, Bernards R. (1999). Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene 18:515–24.
  • Wainszelbaum MJ, Liu J, Kong C, et al. (2012). TBC1D3, a hominoid-specific gene, delays IRS-1 degradation and promotes insulin signaling by modulating p70 S6 kinase activity. PLoS One 7:e31225.
  • Wang PY, Weng J, Anderson RG. (2005). OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science 307:1472–6.
  • Wang W, Huang J, Wang X, et al. (2012). PTPN14 is required for the density-dependent control of YAP1. Genes Dev 26:1959–71.
  • Watanabe N, Arai H, Iwasaki J, et al. (2005). Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc Natl Acad Sci USA 102:11663–8.
  • Weber JD, Raben DM, Phillips PJ, Baldassare JJ. (1997). Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326:61–8.
  • Wei JH, Seemann J. (2009). Mitotic division of the mammalian Golgi apparatus. Semin Cell Dev Biol 20:810–16.
  • Welburn JP, Vleugel M, Liu D, et al. (2010). Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Mol Cell 38:383–92.
  • Westphal RS, Anderson KA, Means AR, Wadzinski BE. (1998). A signaling complex of Ca2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science 280:1258–61.
  • Westphal RS, Coffee RL, Jr, Marotta A, et al. (1999). Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 274:687–92.
  • Wlodarchak N, Guo F, Satyshur KA, et al. (2013). Structure of the Ca2+-dependent PP2A heterotrimer and insights into Cdc6 dephosphorylation. Cell Res 23:931–46.
  • Woods NT, Mesquita RD, Sweet M, et al. (2012). Charting the landscape of tandem BRCT domain-mediated protein interactions. Sci Signal 5:rs6.
  • Wu GS. (2007). Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev 26:579–85.
  • Wu JQ, Hansen DV, Guo Y, et al. (2007). Control of Emi2 activity and stability through Mos-mediated recruitment of PP2A. Proc Natl Acad Sci USA 104:16564–9.
  • Wu X, Noh SJ, Zhou G, et al. (1996). Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells. J Biol Chem 271:3265–71.
  • Wu Z, Chen Y, Yang T, et al. (2012). Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex. PLoS One 7:e43997.
  • Wurzenberger C, Gerlich DW. (2011). Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol 12:469–82.
  • Xie Y, Avello M, Schirle M, et al. (2013). Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation. J Biol Chem 288:2976–85.
  • Xin M, Deng X. (2006). Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J Biol Chem 281:18859–67.
  • Xing H, Hong Y, Sarge KD. (2007). Identification of the PP2A-interacting region of heat shock transcription factor 2. Cell Stress Chaperones 12:192–7.
  • Xing Y, Li Z, Chen Y, et al. (2008). Structural mechanism of demethylation and inactivation of protein phosphatase 2A. Cell 133:154–63.
  • Xing Y, Xu Y, Chen Y, et al. (2006). Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell 127:341–53.
  • Xu P, Raetz EA, Kitagawa M, et al. (2013). BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression. Biol Open 2:479–86.
  • Xu Y, Chen Y, Zhang P, et al. (2008). Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol Cell 31:873–85.
  • Xu Y, Xing Y, Chen Y, et al. (2006). Structure of the protein phosphatase 2A holoenzyme. Cell 127:1239–51.
  • Xu Z, Cetin B, Anger M, et al. (2009). Structure and function of the PP2A-shugoshin interaction. Mol Cell 35:426–41.
  • Xu Z, Williams BR. (2000). The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol 20:5285–99.
  • Yamamoto H, Hinoi T, Michiue T, et al. (2001). Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A. J Biol Chem 276:26875–82.
  • Yan L, Mieulet V, Burgess D, et al. (2010). PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Mol Cell 37:633–42.
  • Yang CS, Xin HW, Kelley JB, et al. (2007). Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions. Mol Cell Biol 27:3390–404.
  • Yang J, Fan GH, Wadzinski BE, et al. (2001). Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem 276:47828–33.
  • Yatim A, Benne C, Sobhian B, et al. (2012). NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48:445–58.
  • Yeong FM, Hombauer H, Wendt KS, et al. (2003). Identification of a subunit of a novel Kleisin-beta/SMC complex as a potential substrate of protein phosphatase 2A. Curr Biol 13:2058–64.
  • Yokoyama N, Miller WT. (2001). Protein phosphatase 2A interacts with the Src kinase substrate p130(CAS). Oncogene 20:6057–65.
  • Yokoyama N, Reich NC, Miller WT. (2001). Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway. J Interferon Cytokine Res 21:369–78.
  • Yoo SJ, Jimenez RH, Sanders JA, et al. (2008). The alpha4-containing form of protein phosphatase 2A in liver and hepatic cells. J Cell Biochem 105:290–300.
  • Yu XX, Du X, Moreno CS, et al. (2001). Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol Biol Cell 12:185–99.
  • Yuan M, Pino E, Wu L, et al. (2012). Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J Biol Chem 287:29579–88.
  • Zhang W, Yang J, Liu Y, et al. (2009). PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation. J Biol Chem 284:22649–56.
  • Zhu D, Kosik KS, Meigs TE, et al. (2004). Galpha12 directly interacts with PP2A: evidence FOR Galpha12-stimulated PP2A phosphatase activity and dephosphorylation of microtubule-associated protein, tau. J Biol Chem 279:54983–6.
  • Zwaenepoel K, Goris J, Erneux C, et al. (2010). Protein phosphatase 2A PR130/B″alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J 24:538–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.